BioWorld Science

Feb. 12, 1998

View Archived Issues

Amgen: Q4 and FY 1997 highlights

Read More

Cel-Sci updates shareholders

Read More

Celtrix: Q3 highlights

Read More

DiagnoCure: Q4 and FY 1997 highlights

Read More

Allergan: FY 1997 highlights

Read More

Panretin update

Read More

Plant extract DA-9601 protects against NSAID-induced gastric damage

Read More

Adenosine agonists with antilipolytic activity described by Glaxo

Read More

Icos reveals new cGMP-specific PDE inhibitors

Read More

Byk Gulden describes new imidazopyridine PDE IV inhibitors

Read More

Celltech reports crosslinked antibodies for cancer indications

Read More

Potential new antimigraine agents in development at Allelix

Read More

Novel approach to HIV therapy described by ML Laboratories

Read More

Zeneca's new antibacterial agents active against resistant pathogens

Read More

Inhibitors of secretory PLA2 produced by Streptomyces violaceusniger

Read More

Chinese investigators evaluate new MDR-reversing agent

Read More

Goralatide: a candidate hematopoietic agent from Beaufour Ipsen

Read More

Roche develops orally active anti-HSV agent that targets viral TK

Read More

U.S. clearance for naratriptan

Read More

CytRx to divest Proceutics subsidiary

Read More

Chiroscience and Bristol-Myers Squibb collaborate on MMP inhibitors for cancer

Read More

Immunomedics terminates CEA-Scan marketing agreements with Mallinckrodt

Read More

Synercid scheduled for FDA committee review next week

Read More

Neurocrine Biosciences and Rigel collaborate on gliosis inhibitors

Read More

Micrologix, PENCE to collaborate on new antibiotics

Read More

Medarex and Schering AG sign antibody agreement

Read More